Codexis (CDXS) Net Margin Growth (1y) (2011 - 2026)

Codexis (CDXS) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1,491.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -653.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Codexis 135.70 Mn 70.56 Mn 13.18 Mn 21,718.00

Historic Data

Download Data
DateValue
Mar 31, 2026 21,718.00
Dec 31, 2025 7,302.00
Sep 30, 2025 -6,722.00
Jun 30, 2025 19,860.00
Mar 31, 2025 -20,688.00
Dec 31, 2024 9,549.00
Sep 30, 2024 21,545.00
Jun 30, 2024 -5,473.00
Mar 31, 2024 10,683.00
Dec 31, 2023 -8,018.00
Sep 30, 2023 -34,730.00
Jun 30, 2023 -22,359.00
Mar 31, 2023 -15,057.00
Dec 31, 2022 -2,207.00
Sep 30, 2022 -3,509.00
Jun 30, 2022 988.00
Mar 31, 2022 2,664.00
Dec 31, 2021 -2,295.00
Sep 30, 2021 3,925.00
Jun 30, 2021 2,563.00